Apotheken | Hôpital | Interactions | LiMA | Médecin | Médicaments | Services | T. de l'Autorisation
Information professionnelle sur Xeomin:Merz Pharma (Schweiz) AG
Information professionnelle complèteDDDAfficher les changementsimprimé 
Composit.Forme gal.Indic./emploiPosolog./mode d'empl.Contre-Ind.PrécautionsInteract.Grossesse
Apt.conduiteEffets indésir.SurdosagePropriétésPharm.cinét.Donn.précl.RemarquesNum. Swissmedic
PrésentationsTitulaireMise à jour 
M03AX01 - Botulinum ToxinATC-DDD Version 2016. Source: WHO
M - Musculo-Skeletal System
M03 - Muscle Relaxants

This group comprises peripherally, centrally and directly acting muscle relaxants.
See also G04BD - Drugs for urinary frequency and incontinence.

M03A - Muscle Relaxants, Peripherally Acting Agents

This group comprises peripherally acting muscle relaxants such as curare alkaloids and suxamethonium.
The drugs in this group are mainly used together with anesthetics.

As for other drugs used in general anesthesia (see N01A), no DDDs have been established in this group because the doses used vary substantially.

M03AX - Other Muscle Relaxants, Peripherally Acting Agents

Botulinum toxin used e.g. for treatment of blepharospasm, hemifacial spasm and migraine is classified in this group.

M03AX01 - Botulinum Toxin
2020 ©ywesee GmbH
Einstellungen | Aide | FAQ | Identification | Contact | Home